A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR)

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Coronary Microvascular Dysfunction
Interventions
DEVICE

Angiography-derived Index of Microcirculatory Resistance

"caIMR will be measured by pressure sensors which are produced by Suzhou Rainmed Medical Technology Co., Ltd.~caIMR is calculated based on angiography images and Hyperemic Pa estimated from resting Pa according to prespecified equation."

DEVICE

Pressure wire-based Index of Microcirculatory Resistance

"IMR will be measured by thermodilution method with pressure wire and arterial physiological detector which are produced by St. Jude Medical.~IMR = Pd ∙Tmn"

Trial Locations (3)

100034

Peking University First Hospital, Beijing

200032

Zhongshan Hospital, Shanghai

430062

Zhongnan Hospital Of Wuhan Uniersity, Wuhan

All Listed Sponsors
collaborator

RainMed Medical Group

INDUSTRY

lead

Ge Junbo

OTHER

NCT05009667 - A Prospective, Multi-center Clinical Trial for Evaluating the Effectiveness and Safety of Online Coronary Angiography-Derived Index of Microcirculatory Resistance (caIMR) | Biotech Hunter | Biotech Hunter